IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | +40.0% | 243 | -80.1% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 1,220 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 1,220 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -71.4% | 1,220 | -69.7% | 0.00% | – |
| Q3 2021 | $35,000 | -93.9% | 4,023 | -92.6% | 0.00% | – |
| Q2 2021 | $575,000 | -29.8% | 54,374 | +6.5% | 0.00% | -100.0% |
| Q1 2021 | $819,000 | -15.8% | 51,040 | +142.4% | 0.00% | 0.0% |
| Q4 2020 | $973,000 | +21.9% | 21,060 | -7.1% | 0.00% | 0.0% |
| Q3 2020 | $798,000 | +3527.3% | 22,658 | +2414.8% | 0.00% | – |
| Q2 2020 | $22,000 | -56.0% | 901 | -71.9% | 0.00% | – |
| Q1 2020 | $50,000 | – | 3,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |